Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Sievers

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|October 19, 2023
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042Sybren L N Maas, Philipp Sievers, Damien C Weber, et al.
Acta Neuropathologica Communications|March 15, 2023
CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasmArnault Tauziède-Espariat, Dominique Figarella-Branger, Alice Métais, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
Acta Neuropathologica Communications|February 14, 2023
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult populationArnault Tauziède-Espariat, Emmanuelle Uro-Coste, Philipp Sievers, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
Acta Neuropathologica Communications|March 19, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomasCatharina Lotsch, Nicoletta Giuliani Canizales, Lena Jassowicz, et al.
Acta Neuropathologica|September 30, 2025
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomasFuat Kaan Aras, Dennis Friedel, Felix Keller, et al.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
Neuropathology and Applied Neurobiology|March 16, 2022
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumoursRomain Appay, Franck Bielle, Philipp Sievers, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|October 19, 2023
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042Sybren L N Maas, Philipp Sievers, Damien C Weber, et al.
Acta Neuropathologica Communications|March 15, 2023
CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasmArnault Tauziède-Espariat, Dominique Figarella-Branger, Alice Métais, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
Acta Neuropathologica Communications|February 14, 2023
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult populationArnault Tauziède-Espariat, Emmanuelle Uro-Coste, Philipp Sievers, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
Acta Neuropathologica Communications|March 19, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomasCatharina Lotsch, Nicoletta Giuliani Canizales, Lena Jassowicz, et al.
Acta Neuropathologica|September 30, 2025
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomasFuat Kaan Aras, Dennis Friedel, Felix Keller, et al.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
Neuropathology and Applied Neurobiology|March 16, 2022
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumoursRomain Appay, Franck Bielle, Philipp Sievers, et al.
Pageof 13